BILLERICA, Mass. - Quanterix (NASDAQ:QTRX) Corporation (NASDAQ: QTRX), a company specializing in ultrasensitive biomarker detection, today announced a rescheduling of its fourth quarter and full year 2023 financial results release to coincide with the filing of its Annual Report on Form 10-K. The revised date for the investor call is now set for Thursday, February...
(Reuters) - Utility firm American Electric Power (NASDAQ:AEP) on Monday reported fourth-quarter earnings that missed analysts\' expectations and named board member Benjamin Fowke as interim chief executive officer, effective immediately. Fowke, the former CEO of peer Xcel Energy (NASDAQ:XEL), will replace Julie Sloat, who had been American Electric\'s chief since January 2023. The change comes...
WICHITA, Kan. - Spirit AeroSystems (NYSE:SPR) Holdings, Inc. [NYSE: SPR], a prominent manufacturer of aerostructures, announced the appointment of Jane P. Chappell to its Board of Directors, effective immediately. Chappell, who brings over four decades of experience in the defense industry, will contribute to the Corporate Governance and Nominating Committee and the Risk Committee. Chappell\'s...
By Chuck Mikolajczak NEW YORK (Reuters) -U.S. stocks ended with modest losses on Monday, as the focus shifted after last week\'s AI-fueled rally to upcoming economic data that could affect the timing of the Federal Reserve\'s expected interest rate cut. The release of January\'s personal consumption expenditures price index (PCE)- the Fed\'s preferred inflation gauge...
-- U.S. stock index futures were muted in evening deals on Monday, after Wall Street indexes were pulled off record peaks by a mix of profit-taking and growing anxiety ahead of key inflation readings this week. Investors were also largely on edge over the prospect of higher-for-longer interest rates, as a slew of Federal Reserve...
COPENHAGEN - The U.S. Food and Drug Administration (FDA) has granted Priority Review for epcoritamab, a potential new treatment for patients with relapsed or refractory follicular lymphoma, announced Genmab A/S (NASDAQ: NASDAQ:GMAB) and AbbVie (NYSE: NYSE:ABBV). This designation could significantly expedite the therapy\'s approval process, with a target action date set for June 28, 2024....
By Ana Mano SAO PAULO (Reuters) - Brazilian poultry and pork processor BRF SA (NYSE:BRFS) turned a profit of 823 million reais ($165.26 million) in the final three months of 2023, according to an earnings statement on Monday, ending a seven-quarter losing streak. Including effects of hyperinflation in Turkey, where it also has large operations,...
PITTSBURGH - Wesco International, Inc. (NYSE: NYSE:WCC) has announced the pricing of a private offering of senior notes by its subsidiary, WESCO Distribution, Inc. The offering includes $900 million of 6.375% senior notes due in 2029 and $850 million of 6.625% senior notes due in 2032. The company has upsized the offering from the initially...
By Byron Kaye and Echha Jain SYDNEY (Reuters) - Australia\'s No. 2 supermarket operator Coles Group (OTC:CLEGF) on Tuesday rejected accusations of price gouging as its first-half profit beat analyst forecasts, saying food inflation was a global problem and its margins were steady. Coles and larger rival Woolworths Group, which together account for two-thirds of...
By Brigid Riley TOKYO (Reuters) - As economic and geopolitical woes spur an exodus of investors from China, many have been redirecting money into Japan, giving the benchmark Nikkei an extra boost as it rockets to all-time highs. While some investors just want to say goodbye to Japan\'s troubled neighbour in embracing the land of...